| Ms Jane Butler Stockwood, MS, FNP-C, CUNP | |
|
1 Va Ctr, Augusta, ME 04330-6719 | |
| (207) 623-8411 | |
| (207) 621-4882 |
| Full Name | Ms Jane Butler Stockwood |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1 Va Ctr, Augusta, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407802325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WU0100X | Registered Nurse - Urology | R021829 (Maine) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | CNP81468 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jane Butler Stockwood, MS, FNP-C, CUNP 1 Va Ctr, Augusta, ME 04330-6719 Ph: (207) 623-8411 | Ms Jane Butler Stockwood, MS, FNP-C, CUNP 1 Va Ctr, Augusta, ME 04330-6719 Ph: (207) 623-8411 |
News Archive
In new research published in the April 4, 2013 issue of The American Journal of Human Genetics, researchers from Brigham and Women's Hospital demonstrate that some variants in our genes that could put a person at risk for inflammatory diseases such as multiple sclerosis, Crohn's disease or rheumatoid arthritis, have been the target of natural selection over the course of human history.
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
The Washington Post reports on the District of Columbia's Medicaid program and mental health coverage. "The federal government handed [the city] an opportunity to save $56 million over four years by expanding Medicaid this summer and they jumped at it. They switched 35,000 low-income residents from the city-funded D.C. Health Care Alliance insurance plan to a Medicaid plan and reaped the reward.
Patients with advanced colorectal tumors without mutations in the RAS genes derive substantial benefit from anti-EGFR therapies; however, the disease eventually progresses, leaving these patients with few alternative therapeutic options.
› Verified 4 days ago
Nicole Letendre, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-626-1360 Fax: 207-626-1359 | |
Pamela Slaughter, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-248-0097 | |
Mr. Stephen G Brewer, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 250 Arsenal St, 11 Shs, Augusta, ME 04333 Phone: 207-624-4657 Fax: 207-287-6123 | |
Ms. Patricia Ann Keohan, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 330 Civic Center Dr, Augusta, ME 04330 Phone: 207-430-4321 Fax: 207-430-4320 | |
H Katrine Alcaide, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 43 Gabriel Dr, Augusta, ME 04330 Phone: 207-248-3932 | |
Jamie Sue Boutin, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 35 Medical Center Pkwy, Augusta, ME 04330 Phone: 207-626-1000 | |
Dr. Michelle Evangeline Breton, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 841 Riverside Dr, Augusta, ME 04330 Phone: 844-294-5306 Fax: 844-294-5306 |